Clinical trials in stroke prevention--persisting uncertainties, firm answers
Barnett, H.J.; Taylor, D.W.
Neurology 43(11): 2163-2166
1993
ISSN/ISBN: 0028-3878 PMID: 8232921 Document Number: 418665
Document emailed within 1 workday
Related Documents
Cairns, J.A. 1992: Coronary thrombolysis--persisting uncertainties about optimal regimens and patient selection Canadian Journal of Cardiology 8(1): 25-28Lutsep, H.L. 2007: New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 16(6): 263-267
Diener, H.C. 1997: Antiplatelet drugs in secondary prevention of stroke: lessons from recent trials Neurology 49(5 Suppl. 4): S75-S81
Kirshner, H.S. 1996: Medical revolution: the prevention and treatment of stroke, 1996. Part 2. Medical prevention of stroke and acute stroke therapy Tennessee Medicine: Journal of the Tennessee Medical Association 89(11): 410-412
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Li, Y.-s. 2010: To modify the design of preclinical trials: a lesson from the failure of neuroprotection trials in stroke Zhonghua Nei Ke Za Zhi 49(9): 733-734
Kirshner, H.S. 1996: Medical revolution: the prevention and treatment of stroke, 1996. Part 1. Stroke prevention and carotid endarterectomy Tennessee Medicine: Journal of the Tennessee Medical Association 89(10): 374-375
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Gordin, F.; Chaisson, R.E.; Matts, J.P.; Miller, C.; de Lourdes Garcia, M.; Hafner, R.; Valdespino, J.L.; Coberly, J.; Schechter, M.; Klukowicz, A.J.; Barry, M.A.; O'Brien, R.J. 2000: Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group JAMA 283(11): 1445-1450
Serdechnaya, E.V.; Yurieva, S.V. 2015: Atrial Fibrillation: Stroke Prevention in Clinical Practice Physician Kardiologiia 55(12): 36-41
Harichund, C.; Haripersad, K.; Ramjee, R. 2013: Participant verification: prevention of co-enrolment in clinical trials in South Africa South African Medical Journal 103(7): 491-493
Hymowitz, N. 1987: Community and clinical trials of disease prevention: effects on cigarette smoking Public Health Reviews 15(1-2): 45-81
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Njogu, W.; Castro-Martin, T. 2006: The persisting gap between HIV/AIDS knowledge and risk prevention among Kenyan youth Genus 62(2): 135-168,6
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518